NVAX - NOVAVAX INC
IEX Last Trade
8.31
-0.100 -1.203%
Share volume: 24,098
Last Updated: Fri 27 Dec 2024 05:29:59 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.39%
PREVIOUS CLOSE
CHG
CHG%
$8.41
-0.10
-1.19%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-10 | 2022-08-09 | 2022-11-09 | 2023-02-28 | 2023-05-09 | 2023-08-08 | 2023-11-09 | 2024-02-28 | |
| Total revenue | 703.971 M | 185.925 M | 734.577 M | 357.399 M | 80.951 M | 424.426 M | 186.986 M | 291.342 M | |
| Cost of revenue | 15.204 M | 271.077 M | 434.593 M | 181.765 M | 34.086 M | 55.777 M | 98.929 M | 154.976 M | |
| Gross profit | 688.767 M | -85.152 M | 299.984 M | 175.634 M | 46.865 M | 368.649 M | 88.057 M | 136.366 M | |
| -112.36% | 452.29% | -41.45% | -73.32% | 686.62% | -76.11% | 54.86% | |||
| Operating expenses | 479.475 M | 397.808 M | 427.173 M | 419.513 M | 359.633 M | 313.192 M | 213.689 M | 319.934 M | |
| Selling general and admin | 95.992 M | 108.160 M | 122.876 M | 161.663 M | 112.532 M | 93.717 M | 107.460 M | 155.237 M | |
| Research and development | 383.483 M | 289.648 M | 304.297 M | 257.850 M | 247.101 M | 219.475 M | 106.229 M | 164.697 M | |
| Total expenses | 494.679 M | 668.885 M | 861.766 M | 601.278 M | 393.719 M | 368.969 M | 312.618 M | 474.910 M | |
| 35.22% | 28.84% | -30.23% | -34.52% | -6.29% | -15.27% | 51.91% | |||
| Operating income | 209.292 M | -482.960 M | -127.189 M | -243.879 M | -312.768 M | 55.457 M | -125.632 M | -183.568 M | |
| Ebit | 209.292 M | -482.960 M | -127.189 M | -243.879 M | -312.768 M | 55.457 M | -125.632 M | -183.568 M | |
| Pretax income | 206.070 M | -509.067 M | -166.141 M | -184.509 M | -292.722 M | 57.865 M | -131.473 M | -176.701 M | |
| -347.04% | -67.36% | 11.06% | 58.65% | -119.77% | -327.21% | 34.40% | |||
| Income tax | 2.662 M | 1.418 M | 2.472 M | -2.260 M | 1.183 M | -143.000 K | -697.000 K | 1.688 M | |
| Net income basic | 203.408 M | -510.485 M | -168.613 M | -182.249 M | -293.905 M | 58.008 M | -130.776 M | -178.389 M | |
| -350.97% | 66.97% | -8.09% | -61.27% | 119.74% | -325.44% | -36.41% | |||
| Net income | 203.408 M | -510.485 M | -168.613 M | -182.249 M | -293.905 M | 58.008 M | -130.776 M | -178.389 M | |
| -350.97% | 66.97% | -8.09% | -61.27% | 119.74% | -325.44% | -36.41% |